These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 17846843

  • 1. Hepatitis B virus infection predicts extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma.
    Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S.
    Ann Surg Oncol; 2007 Nov; 14(11):3181-7. PubMed ID: 17846843
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y, Suzuki S, Baba S, Inaba K, Konno H, Nakamura S.
    J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection.
    Shirabe K, Shimada M, Kajiyama K, Gion T, Ikeda Y, Hasegawa H, Taguchi K, Takenaka K, Sugimachi K.
    Cancer; 1998 Dec 01; 83(11):2312-6. PubMed ID: 9840530
    [Abstract] [Full Text] [Related]

  • 4. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.
    Alcohol Clin Exp Res; 2003 Aug 01; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [Abstract] [Full Text] [Related]

  • 5. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
    Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Togo S.
    Ann Surg Oncol; 2007 Mar 01; 14(3):1170-81. PubMed ID: 17195904
    [Abstract] [Full Text] [Related]

  • 6. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Häussinger D.
    Z Gastroenterol; 1997 Dec 01; 35(12):1059-67. PubMed ID: 9487638
    [Abstract] [Full Text] [Related]

  • 7. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
    Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, Nakanuma Y, Okita K, Omata M, Takayasu K, Yamaoka Y.
    Cancer; 2004 Aug 15; 101(4):796-802. PubMed ID: 15305412
    [Abstract] [Full Text] [Related]

  • 8. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.
    Liver Int; 2005 Apr 15; 25(2):236-41. PubMed ID: 15780044
    [Abstract] [Full Text] [Related]

  • 9. Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma.
    Hanazaki K, Matsushita A, Nakagawa K, Misawa R, Amano J.
    Hepatogastroenterology; 2005 Apr 15; 52(62):552-7. PubMed ID: 15816476
    [Abstract] [Full Text] [Related]

  • 10. Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection.
    Kusano T, Sasaki A, Kai S, Endo Y, Iwaki K, Shibata K, Ohta M, Kitano S.
    Eur J Surg Oncol; 2009 Nov 15; 35(11):1179-85. PubMed ID: 19443173
    [Abstract] [Full Text] [Related]

  • 11. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study.
    Sugita S, Sasaki A, Iwaki K, Uchida H, Kai S, Shibata K, Ohta M, Kitano S.
    Eur J Surg Oncol; 2008 Mar 15; 34(3):339-45. PubMed ID: 17400417
    [Abstract] [Full Text] [Related]

  • 12. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI, Kim JM, Jung GO, Chun JM, Choi GS, Park JB, Kwon CH, Kim SJ, Jo JW.
    Korean J Hepatol; 2008 Jun 15; 14(2):185-96. PubMed ID: 18617766
    [Abstract] [Full Text] [Related]

  • 13. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH, Kim DH, Choi SB, Kang CM, Kim KS, Choi JS, Lee WJ, Han KH, Chon CY, Kim BR.
    J Gastroenterol Hepatol; 2009 Mar 15; 24(3):391-8. PubMed ID: 19032452
    [Abstract] [Full Text] [Related]

  • 14. Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins.
    Matsuda M, Suzuki T, Kono H, Fujii H.
    J Hepatobiliary Pancreat Surg; 2007 Mar 15; 14(3):289-96. PubMed ID: 17520205
    [Abstract] [Full Text] [Related]

  • 15. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J.
    J Gastroenterol Hepatol; 2008 Mar 15; 23(3):459-66. PubMed ID: 17854425
    [Abstract] [Full Text] [Related]

  • 16. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
    Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF.
    Am J Gastroenterol; 2008 Jul 15; 103(7):1663-73. PubMed ID: 18616655
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection.
    Li N, Lai EC, Shi J, Guo WX, Xue J, Huang B, Lau WY, Wu MC, Cheng SQ.
    Ann Surg Oncol; 2010 Jan 15; 17(1):179-85. PubMed ID: 19727956
    [Abstract] [Full Text] [Related]

  • 18. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A, Ishikawa K, Haraguchi N, Inoue H, Ishio T, Shibata K, Ohta M, Kitano S, Mori M.
    Ann Surg Oncol; 2007 Mar 15; 14(3):1191-9. PubMed ID: 17195907
    [Abstract] [Full Text] [Related]

  • 19. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S.
    Eur J Surg Oncol; 2009 Feb 15; 35(2):174-9. PubMed ID: 18325724
    [Abstract] [Full Text] [Related]

  • 20. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C.
    Kaibori M, Matsui Y, Hijikawa T, Uchida Y, Kwon AH, Kamiyama Y.
    Surgery; 2006 Mar 15; 139(3):385-94. PubMed ID: 16546504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.